Elavex 75 mg/150 mg Capsules
PDF Leaflet Revision Date: 30 September 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of depression and anxiety disorders.
Dosage (summary)
Start at 75 mg once daily, may increase to 150 mg; max 375 mg.
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly
Pregnancy & Breastfeeding
Not established; may cause complications in neonates.
Key Drug Interactions
- MAOIs
- CNS active medicines
- Warfarin
- Ethanol
Contraindications
- Hypersensitivity to venlafaxine
- Concomitant MAOI use
- Children under 18
- Pregnancy and lactation
Common side effects
- Headache
- Dizziness
- Insomnia
- Dry mouth
- Nausea
Counselling Points
- Take with food.
- Do not crush or chew capsules.
- Monitor for mood changes.
- Taper off gradually.
Serious warnings
- Risk of suicidal thoughts
- Serotonin syndrome
- Increased blood pressure
- Convulsions
Important Disclaimer
The Elavex 75 mg/150 mg Capsules professional information leaflet below is the property of Accord Healthcare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
